CS logo
small CS logo
Kromerizska Nemocnice, a.s.

Kromeriz, Czech Republic
Hospital in Kroměříž
Havlíčkova 660/69, 767 01 Kroměříž

About Kromerizska Nemocnice, a.s.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Ferring Pharmaceuticals
5
Advanz Pharma
1
Bayer
1
Daiichi Sankyo, Inc.
1
Janssen Research & Development, LLC
1
Total Rows: 5

Clinical Trials at Kromerizska Nemocnice, a.s.


During the past decade, Kromerizska Nemocnice, a.s. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100002200000000Started TrialsCompleted Trails20172018201920200123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
2007-03-01
2008-07-01
Completed
735
A Trial of Degarelix in Patients With Prostate Cancer
2009-06-01
2011-03-01
Completed
859
A Study of Minirin Melt in Patients With Nocturia
2010-01-01
2013-12-01
Completed
2,187
A Study of Minirin Melt in Patients With Nocturia
2008-09-01
2011-03-01
Completed
588
A Degarelix Trial in Patients With Prostate Cancer
2010-10-01
2012-01-01
Terminated
288
A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia
2012-03-01
2016-04-01
Completed
4,136
Comparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical Outcomes
2017-01-24
2018-10-09
Completed
607
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
2020-09-14
2024-09-13
Active, not recruiting
6,016

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Kromerizska Nemocnice, a.s." #1 sponsor was "Ferring Pharmaceuticals" with 5 trials, followed by "Advanz Pharma" with 1 trials sponsored, "Bayer" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kromerizska Nemocnice, a.s." #1 collaborator was "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsFerring Pharmaceuticals: 5Ferring Pharmaceuticals: 5Advanz Pharma: 1Advanz Pharma: 1Bayer: 1Bayer: 1Daiichi Sankyo, Inc.: 1Daiichi Sankyo, Inc.: 1Janssen Research &Development, LLC: 1Janssen Research &Development, LLC: 1

Created with Highcharts 11.1.0Top CollaboratorsQuintiles, Inc.: 1Quintiles, Inc.: 1

Clinical Trials Conditions at Kromerizska Nemocnice, a.s.


According to Clinical.Site data, the most researched conditions in "Kromerizska Nemocnice, a.s." are "Nocturia" (3 trials), "Atrial Fibrillation" (2 trials), "Prostate Cancer" (2 trials), "Heart Failure" (1 trials) and "Urinary Bladder Neoplasms" (1 trials). Many other conditions were trialed in "Kromerizska Nemocnice, a.s." in a lesser frequency.

Clinical Trials Intervention Types at Kromerizska Nemocnice, a.s.


Most popular intervention types in "Kromerizska Nemocnice, a.s." are "Drug" (6 trials), "Biological" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Degarelix" (2 trials), "Goserelin acetate" (2 trials), "Placebo" (2 trials), "Cetrelimab" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Kromerizska Nemocnice, a.s.


The vast majority of trials in "Kromerizska Nemocnice, a.s." are 7 trials for "All" genders and 2 trials for "Male" genders.

Clinical Trials Status at Kromerizska Nemocnice, a.s.


Currently, there are NaN active trials in "Kromerizska Nemocnice, a.s.". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Kromerizska Nemocnice, a.s., undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Kromerizska Nemocnice, a.s., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4Not Applicable: 1Not Applicable: 1Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 6Completed: 6Active, not recruiting: 1Active, not recruiting: 1Recruiting: 1Recruiting: 1Terminated: 1Terminated: 1